Olympus increases endoscopy sales, monitors supply chain issues

The Covid-19 pandemic challenges are easing up for Olympus, but the company still predicts uncertain supply chains, higher costs and trading challenges between the US and China. Still, endoscopy sales have gone well at the Japanese medtech giant.
Photo: Yuriko Nakao/Reuters/Ritzau Scanpix
Photo: Yuriko Nakao/Reuters/Ritzau Scanpix
by ULRICH QUISTGAARD, translated by daniel pedersen

Japanese Olympus has added 22 percent to its revenue in the first nine months of the financial year, as reported in the medtech company’s third quarter figures.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading